The global oat beta-glucan market size is likely to reach US$ 623.2 Million in 2022. Increasing consumption of oats owing to the changing dietary patterns of consumers is set to augment the demand for oat beta-glucan in the near future. As per FMI, the oat beta-glucan market is expected to reach US$ 846.1 Million in 2032 and exhibit growth at a CAGR of 8.3% in the forecast period from 2022 to 2032.
| Report Attribute | Details |
|---|---|
| Oat Beta-Glucan Market Estimated Base Year Value (2021) | US$ 511.8 Million |
| Oat Beta-Glucan Market Expected Market Value (2022) | US$ 623.2 Million |
| Oat Beta-Glucan Market Anticipated Forecast Value (2032) | US$ 846.1 Million |
| Oat Beta-Glucan Market Projected Growth Rate (2022 to 2032) | 8.3% CAGR |
Oat beta-glucan is considered to be a water-soluble glucan that is mainly derived from the endosperm of oat kernels. It is gaining immense popularity owing to its dietary contribution as a major component of soluble fiber.
Its ability to reduce the risk of cardiovascular diseases is a major factor that is likely to push sales of oat beta-glucan in the upcoming years. It is capable of reducing the low-density lipoprotein cholesterol, as well as serum total cholesterol.
Oat beta-glucan is nowadays used in the cosmetics and personal care industry. Manufacturers are utilizing it to produce powders, ointments, and lotions as it can reduce the risk of skin disorders and initiate the development of collagen.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Increasing demand for clean-label ingredients across the globe is expected to bolster the market in future. Consumers are seeking natural products that would help in keeping them fit without changing the taste of food items. Thus, manufacturers are likely to conduct exhaustive research and development activities to come up with novel oat beta-glucan-based products.
Moreover, increasing prevalence of cardiovascular health problems among people in developed and emerging economies is likely to propel the need for oat beta-glucan. As per the World Health Organization (WHO), in 2019, about 17.9 million people died from cardiovascular diseases worldwide. This number is expected to surge at a fast pace, thereby propelling the global oat beta-glucan market growth.
Lack of knowledge about the availability of various nutritious food and beverage options infused with organic ingredients, especially in underdeveloped countries may hinder the demand for oat beta-glucan in the evaluation period. Besides, the poor healthcare infrastructure in these countries and the lack of government funding to support the development of nutritious products are anticipated to hinder growth.
Principal Consultant
Based on region, North America is projected to remain at the forefront by generating the largest oat beta-glucan market share. This growth is attributable to the rising geriatric population in the U.S. and Canada. Older people are more prone to develop heart diseases and this factor is likely to influence the North America market.
According to the Centers for Disease Control and Prevention (CDC), in the U.S., 1 person dies every 36 seconds from cardiovascular disease and around 659,000 people in the country die from heart disease every year. This trend is expected to continue throughout the forthcoming years, thereby augmenting the North America market.
Increasing awareness in developing countries, such as India and China regarding the benefits of consuming dietary supplements is a vital factor that is set to propel the Asia Pacific market growth. High demand for these supplements among athletes and sports personnel across Asia Pacific is another factor that would fuel the sales of oat beta-glucan in the region.
Besides, ongoing development of the pharmaceutical industry in Asia Pacific is expected to contribute to growth. Oat beta-glucan is often used in the production of medicines to help treat certain diseases. Rising investments by several multinational manufacturers in the expansion of their distribution networks across Asia Pacific would also aid growth.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the most prominent companies operating in the global oat beta-glucan market include Ceapro Inc., Koninklijke DSM N.V., Fazer, Naturex, Tate & Lyle PLC, and Garuda International, Inc. among others.
The majority of the leading players operating in this market are adopting various organic and inorganic strategies to gain a competitive edge. They are engaging in mergers & acquisitions, joint ventures, agreements, and partnerships with local and international players to compete with their rivals. A few other companies are aiming to launch new products by investing in research and development activities.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 8.3% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Nature, End Use, Region |
| Regions Covered | North America; Latin America; Western Europe; Eastern Europe; APEJ; Japan; Middle East and Africa |
| Key Countries Profiled | USA, Canada, Brazil, Argentina, Germany, UK, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, ASEAN, GCC, South Africa |
| Key Companies Profiled | Ceapro Inc.; Koninklijke DSM N.V.; Fazer; Naturex; Tate & Lyle PLC; Garuda International, Inc. |
| Customization | Available Upon Request |
The global oat beta-glucan market is set to surpass US$ 846.1 Million in 2032.
North America is set to lead the oat beta-glucan market in the forecast period.
Ceapro Inc., Koninklijke DSM N.V., Fazer, Naturex, Tate & Lyle PLC, and Garuda International, Inc. are some of the renowned companies in the oat beta-glucan market.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. By Nature 6.2. By End Use 7. Global Market Analysis and Forecast, By Nature 7.1. Organic 7.2. Conventional 8. Global Market Analysis and Forecast, By End Use 8.1. Food and Beverage 8.2. Pharmaceutical 8.3. Nutraceutical 8.4. Dietary Supplements 8.5. Cosmetic and Personal Care 8.6. Animal Nutrition 9. Global Market Analysis and Forecast, By Region 9.1. North America 9.2. Latin America 9.3. Western Europe 9.4. Eastern Europe 9.5. APEJ 9.6. Japan 9.7. Middle East and Africa 10. North America Sales Analysis and Forecast, by Key Segments and Countries 11. Latin America Sales Analysis and Forecast, by Key Segments and Countries 12. Western Europe Sales Analysis and Forecast, by Key Segments and Countries 13. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries 14. APEJ Sales Analysis and Forecast, by Key Segments and Countries 15. Japan Sales Analysis and Forecast, by Key Segments and Countries 16. Middle East and Africa Sales Analysis and Forecast, by Key Segments and Countries 17. Sales Forecast by Nature and End Use for 30 Countries 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 19. Company Profile 19.1. Ceapro Inc. 19.2. Koninklijke DSM N.V. 19.3. Fazer 19.4. Naturex 19.5. Tate & Lyle PLC 19.6. Garuda International, Inc.
Explore Food and Beverage Insights
View Reports
Oat Beta-Glucan Market
